Andy Warren

- Key synthetic contributor to pre-clinical medicinal projects spanning many therapeutic areas, exemplified by the discovery and subsequent launch of the anti-viral HIV drug Maraviroc/Celsentri(TM) and numerous NCE candidate nominations for development. - Extensive experience of practical synthetic organic chemistry and purification techniques in small and medium scale synthesise with particular emphasis on ease, efficiency, quality, speed and safety leading to enhanced and sustained productivity, in tandem with gaining a reputation for delivering objectives within timelines. - Skilled in early stage research (HTS lead discovery and Fragment) chemistry, utilising parallel chemistry and new technologies to quickly and efficiently probe chemical space and SAR. A track record of of developing singleton chemistry approaches into parallel amenable protocols for rapid analogue synthesis. - Experienced and knowledgable in the provision of large scale material with the required and desired level of potency/purity for toxicological studies to underpin POC/development programs. - Experienced in the remote management of teams of research chemists in India and UK, providing support, problem solving, agreeing priorities and timelines to ensure a constant output/delivery of high quality test compounds and intermediates for mulitple projects.

Industrial placement at Roche Products Limited, Welwyn Garden City. Synthetic organic chemistry Industrial Trainee within the Cardiovascular medicinal chemistry department.